27 Feb, EOD - Indian

Nifty 50 25178.65 (-1.25)

Nifty Pharma 22952.35 (-1.50)

Nifty Next 50 69710.9 (-1.30)

Nifty Bank 60529 (-1.08)

Nifty Midcap 100 59115.6 (-1.14)

Nifty Smallcap 100 16928.9 (-1.10)

SENSEX 81287.19 (-1.17)

Nifty IT 30603.85 (0.16)

27 Feb, EOD - Global

NIKKEI 225 58850.27 (0.16)

HANG SENG 26630.54 (0.95)

S&P 6901 (-0.45)


Stock Alert News

You are Here : Home > News > Stock Alert News >

(16 Dec 2025, 07:29)

Stock Alert: Atlantaa, Hyundai Motor, Solex Energy, Zydus Lifesciences, Arvind SmartSpaces


Securities in F&O Ban:

Bandhan Bank shares are banned from F&O trading on 16 December 2025.

IPO Update:

ICICI Prudential AMC: The public issue was subscribed to 2.11 times on day 2. The bids were led by Qualified institutional investors (2.91 times), non-institutional investors (3.79 times), retail investors (0.83 times).

IPO Opening:

KSH International:The company is the third-largest manufacturer and the largest exporter of magnet winding wires, has opened its initial public offering. Operating under the ‘KSH’ brand, the company supplies to OEMs across sectors such as power, renewables, railways, automotive, and industrials.

The IPO comprises a fresh issue worth Rs 420 crore and an offer for sale of Rs 290 crore. The price band has been fixed at Rs 365 to Rs 384 per share. Ahead of the issue, the company raised Rs 213 crore from anchor investors.

Stocks to Watch:

Atlantaa said that it has entered into a development agreement with Highway Milton Co-operative Housing Society for the redevelopment of a residential project in Borivali, Mumbai. The project is estimated to have a gross development value (GDV) of around Rs 500 crore.

Hyundai Motor said its shareholders have approved the appointment of Tarun Garg as managing director (MD) and chief executive officer (CEO), effective 1 January 2026.

Solex Energy said that it has partnered with Malaysia-based TT Vision to boost solar manufacturing and engineering capabilities in India.

Zydus Lifesciences said the USFDA has accepted the resubmission of the new drug application for CUTX-101. The drug, a copper histidinate, is indicated for the treatment of Menkes disease in pediatric patients.

Arvind SmartSpaces said that it has acquired a new residential high-rise project in Bengaluru, with an estimated revenue potential of nearly Rs 550 crore.

More News

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +